Definition
It is a group of malignant
disorder, affecting theblood and
blood –forming tissue of the bone
marrow lymph system and spleen.
The word Leukemia comesfrom
the Greek leukos which means
"white" and aimawhich means
"blood".
The stem cells are committed to
produce specific types of blood
cells. Lymphoid stemcells produce
either T or Blymphocytes.
Myeloid stem cellsdifferentiate
into three broad cell types:
RBCs, WBCs, and platelets.
Function of the bonemarrow
The bone marrow is found in the inside of
bones. The marrow in the large bones of
adults produces blood cells. Approximately
4% of our total bodyweight consists of bone
marrow.
There are two types of bone marrow:
1.Red marrow, made up mainly of myeloid
tissue.
2. Yellow marrow, made up mostly of fat
cells.
Red marrow can be found in the flat
bones, such as the breast
bone, skull, vertebrae, shoulder
blades, hip bone and ribs. Red marrow
can also be found at the ends of long
bones, such as the humerus and femur.
White blood cells (lymphocytes), red blood
cells and platelets are produced in the red
marrow. Red blood cells carry oxygen, white
blood cells fight diseases. Platelets are
essential for blood clotting.
Yellow marrow can be found in the inside of
the middle section of long bones.
White blood cells, which help to body fight
infection.
Red blood cells, which carry oxygen to all
parts of the body.
Platelets, which help in blood clot.
If a person loses a lot of blood the body can
convert yellow marrow to red marrow in
order to raise blood cell production.
Leukemia
Definition
It is a groupof malignant
disorder, affecting the blood and blood
–forming tissue of the bone marrow
lymph system and spleen.
etiology
Combination of predisposing factors
including genetic and environmental
influences.
Chronic exposure to chemical such as
benzene
Radiation exposure.
Cytotoxic therapy of breast, lung and
testicular cancer.
Congenital anomaly
The presence of primary
immunodeficiency and infection
with the human T –cell leukemia
virus type-1
PATHOPHYSIOLOGY
The lack of control causes–
nomal bone marrow to be replaced by
immature and undifferentiated
leukocytes or blat cells . –
abnormal immature leukocytes then
circulates in the blood and infiltrate
the blood forming organs ( liver
, spleen, lymph nodes) and other sites
throughout the body.
Different types ofleukemia
It may be acute or chronic. Acute
leukemia gets worse very fast and
may make feel sick right away.
Chronic leukemia gets worse slowly
and may not cause symptoms for
years.
Lymphocytic and Myelogenous
Leukemias are also subdivided into
the type of affected blood cell. If
the cancerous transformation
occurs in the type of marrow that
makes lymphocytes, the disease is
called lymphocytic leukemia.
If the cancerous change occurs in the
type of marrow cells that produce red
blood cells, other types of white
cells, and platelets, the disease is
called myelogenous leukemia
FRENCH-AMERICAN–BRITISH
(FAB)CLASSIFICATIONOFACUTE
LEUKEMIA
INCIDENCE—
In adults, chronic lymphocytic leukemia
(CLL) and acute myelogenous leukemia
(AML) are the most common leukemias.
In children, the most common leukemia is
acute lymphoblastic leukemia(ALL).
Childhood leukemias also include acute
myelogenous leukemia (AML) and other
myeloid leukemias, such as chronic
myelogenous leukemia (CML) andjuvenile
myelomonocytic leukemia (JMML).
Relate to problems caused by
Bone marrow failure
Overcrowding by abnormal cells
Inadequate production of normal
marrow elements
Anemia, thrombocytopenia, ↓ number
and function ofWBCs
Relate to problems caused by
Leukemic cells infiltrate
patient’s organs
Splenomegaly
Hepatomegaly
Lymphadenopathy
Bone pain, meningeal
irritation, oral lesions
(chloromas)
Classification of leukaemia
1. 1.Acute lymphatic leukaemia (ALL)
Usually occurs before 14years of age peak
incidence is between 2-9 years of age, older adult
Pathophysiology
It arising from a single lymphoid stem cell, with
impaired maturation and accumulation of the
malignant cells in the bone marrow.
Acute lymphatic leukaemiaCont.
Signs and symptoms
Anaemia, bleeding, lymphadenopathy, infection
Clinical manifestation Clinical manifestation
Fever
Pallor
Bleeding
Anorexia
Fatigue
Weakness
Bone, joint and
abdominal pain
Increase intracranial
press.
 Generalized lymphadenopathy
 Infection of respiratory tract
 Anaemia and bleedingof mucus
membrane
 Weight lossa
 Mouth sore
Acute lymphatic leukaemiaCont.
Diagnosis
 Low RBCs count, Hb, Hct, low platelet count , low
normal or high WBC count.
 Blood smear show immature lymph blasts.
Treatment
Chemotherapeutic agent, it involve three phases
1. Induction: Using vincristine and prednisone.
2. Consolidation: Using modified course of
intensive therapy to eradicate any remaining.
3. Maintenance
Acute lymphatic leukaemiaCont.
Treatment Cont.
 Prophylactic treatment of the CNS
, intrathecal administration and /or
craniospinal radiation witheradicate
leukemic cells.
 Eat diet that contains high in
protein, fibres and fluids.
Acute lymphatic leukaemiaCont.
Treatment Cont.
 Avoid infection (hand washing,avoid
crowds),injury
 Take measure to decrease nausea and to
promote appetite, smoking and spicy
and hot foods.
 Maintain oral hygiene.
ALLHistology
(AML)
It occurs at any age but occurs most often at
adolescence and after age of 55
Pathophysiology
Characterized by the development of immature
myeloblasts in the bone marrow.
Clinical manifestation
Similar to ALLplus sternal tenderness.
Management
Diagnosis
Low RBC, Hb, Hct, low platelet count, low to high
WBC count withmyeloblasts.
Acute Myelogenous Leukaemia(AML) Cont.
Treatment
Use of cytarabine, 6-thioquanine,and
doxorubic
The same care of client as All, plus give
adequate amounts of fluids(2000 to 3000
ml per day.)
Instruct clientabout
medication, effects, side effects and nursing
measures
AML Histology
Chronic lymphocytic Leukaemia
(CLL)
The incidence of CLl increases with age and is rare
under the age of 35.It is common in men.
Pathophysiology
It is characterized by proliferation of
small, abnormal , mature Blymphocytes, often
leading to decreased synthesis of immunoglobulin
anddepressed antibody response.
The number of mature lymphocytes in peripheral
blood smear and bone marrow are greatly
increased
Chronic lymphocytic Leukaemia (CLL)Cont
Clinical Manifestation
Usually there is no symptoms.
Chronic fatigue , weakness , anorexia, splenomegaly
, lymphadenopathy, hepatomegaly.
Signs and Symptoms
 Pruritic vesicular skin lesions .
 Anaemia
 Thrombocytopenia.
 The WBC count is elevated to a level between
20,000 to 100,000.
 Increase blood viscosity and clotting episode.
Chronic lymphocytic Leukaemia (CLL)Cont
Management
I. Persons are treated only when symptoms, particular
anaemia , thrombocytopenia , enlarged lymph
nodes and spleen appear.
I. Chemotherapy agents such as chlorambucil , and
the glucocorticoids.
I. Client and family education is that describe for
AML.
CLLHistology
Chronic Myelogenous
Leukaemia(CML)
Philadelphia chromosome
The chromosome abnormalitythat
causes chronic myeloidleukemia
Occurs between 25-60 years of age. Peak 45
year
It is caused by benzene exposure and high
doses of radiation.
Clinical Manifestation
There is no symptoms in disease. The classic
symptoms, include:
Fatigue, weakness, fever.
Weight loss, joint &bone pain.
Chronic Myelogenous Leukaemia(CML)Cont.
Clinical Manifestation Cont.
Massive splenomegaly
 The accelerated phase of disease(blostic
phase) is characterized by increasing
number of granulocytes in the peripheral
blood.
There is a corresponding anaemia and
thrombocytopenia.
Chronic Myelogenous
Leukaemia(CML)Cont.
Diagnosis
Lower RBC count, Hb, Hct, high platelet
count early, lower count later.
Normal number of lymphocytes and normal
or low number of monocytes in WBC .
Treatment
The commonly drugs are hydroxyurea and
busulfan (monitor of WBC count needed
with therapy).
The only potential curative therapy of CML is
thebone marrow transplant.
Nursing Intervention
Taking measures to prevent infection.
Promoting safety.
Providing oral hygiene.
Preventing fatigue.
Promoting effectivecoping.
Client andfamily education.
CMLHISTOLOGY
MANAGEMENT
watchful waiting,
chemotherapy,
targeted therapy,
radiation therapy, and
stem cell transplant.
Thechoice of treatmentdepends
mainly on the following:
The type of leukemia (acute or chronic)
Age
Whether leukemia cells were found in
cerebrospinal fluid
WATCHFULWAITING
chronic leukemia without
symptoms, may not need cancer
treatment rightaway.
Watch for health closely so that
treatment can start when it begin to
have symptoms.
Not getting cancer treatment right
away is called watchful waiting.
chemotherapy
People with acute leukemia need to be
treated right away.
The goal of treatment is to destroy
signs of leukemia in the body and make
symptoms go away. This is called a
remission.
After people go into remission, more
therapy may be given to prevent a
relapse.
The3 phasesof treatment
protocols are;
Induction phase; the usual
criteria for complete remission are
5% of the bone marrow cells and
normal peripheral blood counts.
Once remission completes the
consolidation phase begins.
Consolidation phase; modified
course of intensive chemotherapy are
given to eradicate any remaining
disease. Usually a higher dose of 1or
more chemotherapeutic agents are
administered.
Maintainance phase; small dose of
different combination of
chemotheraptic agents are given every
3 to 4 weeks. This phase may continue
for a year or longer and is structured to
allow the client to live as normal life as
possible
Targetedtherapy
This affects only tumor cells and spare
normal cells. hence decreasing the
associated toxicities. Gemtuzumab
ozofamicin (mylotarg) is an anti
D33nmonoclonal antibody linked to
calicheamicin, which is potent
cytotoxic agent.
STEM CELLTRANSPLANT
Goal;
Totally eliminate leukemic cells from the body
using combinations of chemotherapy with or
without total bodyirradiation
Eradicates patient’s hematopoietic stem cells
Replaced with those of an HLA-matched
(Human LeukocyteAntigen)
Sibling (is a brother or a sister; that
is, any person who shares at least one of
the same parents )
Volunteer
Identical twin
Patient’s own stemcells removed
before
TYPESOFSTEMCELLTRANSPLANTATION
1.Allogeneic StemCell Transplant
stem cells are taken from a matching donor.
To determine if a donor’s stem cells are the
right match, the patient undergoes a
human leukocyte antigens (HLA) test.
Through this test, we compare the patient’s
blood and tissue type against blood
samples from thedonor.
Donors may include:
HLA-matched relative (most often a sibling)
HLA-matched unrelated donor
HLA miss-matched family member
Unrelated umbilical cord blood
2. Autologous Stem Cell Transplant
In this type of transplant, stem cells are
collected from the patient themselves. The
stem cells are then harvested, frozen and
stored, and then given back to the patient.
This type of transplant is rare for leukemia
patients and is typically used in select cases
of AML.
Nutrition and Physical Activity
It's important for you to take care of eating
well and staying as active.
right amount of calories to maintain a good
weight. enough protein. Eating well may
help to feel better and have more energy.
Follow-up Care
regular checkups after treatment for
leukemia.
NURSING MANAGEMENT
Nursing diagnosis
1.Impaired oral mucous membrane relatedto
low platelet counts or effect of pathologic
conditions and treatment.
2. Ineffective therapeutic management related
to lack of knowledge of disease process, activity
and medication.
3. imbalanced nutrition less than body
requirement reated to anorexia , pain and
fatigue.
4. risk for injury related to low platelet counts
and treatment
Overall goals
Understand and cooperate with the
treatment plan
Experience minimal side effects and
complications of disease and treatment
Feel hopeful and supported during the
periods of treatment, relapse, and
remission
Many physical and psychologicalneeds
Evokes great fear
Goals of rehabilitation
Manage
Physical
Psychosocial
Social
Spiritual
Delayed effects
Support groups
CONCLUSION

Leukemia

  • 2.
    Definition It is agroup of malignant disorder, affecting theblood and blood –forming tissue of the bone marrow lymph system and spleen.
  • 3.
    The word Leukemiacomesfrom the Greek leukos which means "white" and aimawhich means "blood".
  • 4.
    The stem cellsare committed to produce specific types of blood cells. Lymphoid stemcells produce either T or Blymphocytes. Myeloid stem cellsdifferentiate into three broad cell types: RBCs, WBCs, and platelets.
  • 6.
    Function of thebonemarrow The bone marrow is found in the inside of bones. The marrow in the large bones of adults produces blood cells. Approximately 4% of our total bodyweight consists of bone marrow. There are two types of bone marrow: 1.Red marrow, made up mainly of myeloid tissue. 2. Yellow marrow, made up mostly of fat cells.
  • 7.
    Red marrow canbe found in the flat bones, such as the breast bone, skull, vertebrae, shoulder blades, hip bone and ribs. Red marrow can also be found at the ends of long bones, such as the humerus and femur.
  • 8.
    White blood cells(lymphocytes), red blood cells and platelets are produced in the red marrow. Red blood cells carry oxygen, white blood cells fight diseases. Platelets are essential for blood clotting. Yellow marrow can be found in the inside of the middle section of long bones.
  • 9.
    White blood cells,which help to body fight infection. Red blood cells, which carry oxygen to all parts of the body. Platelets, which help in blood clot. If a person loses a lot of blood the body can convert yellow marrow to red marrow in order to raise blood cell production.
  • 10.
    Leukemia Definition It is agroupof malignant disorder, affecting the blood and blood –forming tissue of the bone marrow lymph system and spleen.
  • 11.
    etiology Combination of predisposingfactors including genetic and environmental influences. Chronic exposure to chemical such as benzene Radiation exposure. Cytotoxic therapy of breast, lung and testicular cancer.
  • 12.
    Congenital anomaly The presenceof primary immunodeficiency and infection with the human T –cell leukemia virus type-1
  • 13.
  • 14.
    The lack ofcontrol causes– nomal bone marrow to be replaced by immature and undifferentiated leukocytes or blat cells . – abnormal immature leukocytes then circulates in the blood and infiltrate the blood forming organs ( liver , spleen, lymph nodes) and other sites throughout the body.
  • 15.
    Different types ofleukemia Itmay be acute or chronic. Acute leukemia gets worse very fast and may make feel sick right away. Chronic leukemia gets worse slowly and may not cause symptoms for years.
  • 16.
    Lymphocytic and Myelogenous Leukemiasare also subdivided into the type of affected blood cell. If the cancerous transformation occurs in the type of marrow that makes lymphocytes, the disease is called lymphocytic leukemia.
  • 17.
    If the cancerouschange occurs in the type of marrow cells that produce red blood cells, other types of white cells, and platelets, the disease is called myelogenous leukemia
  • 19.
  • 21.
    INCIDENCE— In adults, chroniclymphocytic leukemia (CLL) and acute myelogenous leukemia (AML) are the most common leukemias. In children, the most common leukemia is acute lymphoblastic leukemia(ALL). Childhood leukemias also include acute myelogenous leukemia (AML) and other myeloid leukemias, such as chronic myelogenous leukemia (CML) andjuvenile myelomonocytic leukemia (JMML).
  • 22.
    Relate to problemscaused by Bone marrow failure Overcrowding by abnormal cells Inadequate production of normal marrow elements Anemia, thrombocytopenia, ↓ number and function ofWBCs
  • 23.
    Relate to problemscaused by Leukemic cells infiltrate patient’s organs Splenomegaly Hepatomegaly Lymphadenopathy Bone pain, meningeal irritation, oral lesions (chloromas)
  • 24.
    Classification of leukaemia 1.1.Acute lymphatic leukaemia (ALL) Usually occurs before 14years of age peak incidence is between 2-9 years of age, older adult Pathophysiology It arising from a single lymphoid stem cell, with impaired maturation and accumulation of the malignant cells in the bone marrow.
  • 25.
    Acute lymphatic leukaemiaCont. Signsand symptoms Anaemia, bleeding, lymphadenopathy, infection Clinical manifestation Clinical manifestation Fever Pallor Bleeding Anorexia Fatigue Weakness Bone, joint and abdominal pain Increase intracranial press.
  • 26.
     Generalized lymphadenopathy Infection of respiratory tract  Anaemia and bleedingof mucus membrane  Weight lossa  Mouth sore
  • 27.
    Acute lymphatic leukaemiaCont. Diagnosis Low RBCs count, Hb, Hct, low platelet count , low normal or high WBC count.  Blood smear show immature lymph blasts. Treatment Chemotherapeutic agent, it involve three phases 1. Induction: Using vincristine and prednisone. 2. Consolidation: Using modified course of intensive therapy to eradicate any remaining. 3. Maintenance
  • 28.
    Acute lymphatic leukaemiaCont. TreatmentCont.  Prophylactic treatment of the CNS , intrathecal administration and /or craniospinal radiation witheradicate leukemic cells.  Eat diet that contains high in protein, fibres and fluids.
  • 29.
    Acute lymphatic leukaemiaCont. TreatmentCont.  Avoid infection (hand washing,avoid crowds),injury  Take measure to decrease nausea and to promote appetite, smoking and spicy and hot foods.  Maintain oral hygiene.
  • 30.
  • 31.
    (AML) It occurs atany age but occurs most often at adolescence and after age of 55 Pathophysiology Characterized by the development of immature myeloblasts in the bone marrow. Clinical manifestation Similar to ALLplus sternal tenderness. Management Diagnosis Low RBC, Hb, Hct, low platelet count, low to high WBC count withmyeloblasts.
  • 32.
    Acute Myelogenous Leukaemia(AML)Cont. Treatment Use of cytarabine, 6-thioquanine,and doxorubic The same care of client as All, plus give adequate amounts of fluids(2000 to 3000 ml per day.) Instruct clientabout medication, effects, side effects and nursing measures
  • 33.
  • 34.
    Chronic lymphocytic Leukaemia (CLL) Theincidence of CLl increases with age and is rare under the age of 35.It is common in men. Pathophysiology It is characterized by proliferation of small, abnormal , mature Blymphocytes, often leading to decreased synthesis of immunoglobulin anddepressed antibody response. The number of mature lymphocytes in peripheral blood smear and bone marrow are greatly increased
  • 35.
    Chronic lymphocytic Leukaemia(CLL)Cont Clinical Manifestation Usually there is no symptoms. Chronic fatigue , weakness , anorexia, splenomegaly , lymphadenopathy, hepatomegaly. Signs and Symptoms  Pruritic vesicular skin lesions .  Anaemia  Thrombocytopenia.  The WBC count is elevated to a level between 20,000 to 100,000.  Increase blood viscosity and clotting episode.
  • 36.
    Chronic lymphocytic Leukaemia(CLL)Cont Management I. Persons are treated only when symptoms, particular anaemia , thrombocytopenia , enlarged lymph nodes and spleen appear. I. Chemotherapy agents such as chlorambucil , and the glucocorticoids. I. Client and family education is that describe for AML.
  • 37.
  • 38.
    Chronic Myelogenous Leukaemia(CML) Philadelphia chromosome Thechromosome abnormalitythat causes chronic myeloidleukemia
  • 39.
    Occurs between 25-60years of age. Peak 45 year It is caused by benzene exposure and high doses of radiation. Clinical Manifestation There is no symptoms in disease. The classic symptoms, include: Fatigue, weakness, fever. Weight loss, joint &bone pain.
  • 40.
    Chronic Myelogenous Leukaemia(CML)Cont. ClinicalManifestation Cont. Massive splenomegaly  The accelerated phase of disease(blostic phase) is characterized by increasing number of granulocytes in the peripheral blood. There is a corresponding anaemia and thrombocytopenia.
  • 41.
    Chronic Myelogenous Leukaemia(CML)Cont. Diagnosis Lower RBCcount, Hb, Hct, high platelet count early, lower count later. Normal number of lymphocytes and normal or low number of monocytes in WBC . Treatment The commonly drugs are hydroxyurea and busulfan (monitor of WBC count needed with therapy).
  • 42.
    The only potentialcurative therapy of CML is thebone marrow transplant. Nursing Intervention Taking measures to prevent infection. Promoting safety. Providing oral hygiene. Preventing fatigue. Promoting effectivecoping. Client andfamily education.
  • 43.
  • 44.
  • 45.
    Thechoice of treatmentdepends mainlyon the following: The type of leukemia (acute or chronic) Age Whether leukemia cells were found in cerebrospinal fluid
  • 46.
    WATCHFULWAITING chronic leukemia without symptoms,may not need cancer treatment rightaway. Watch for health closely so that treatment can start when it begin to have symptoms. Not getting cancer treatment right away is called watchful waiting.
  • 47.
    chemotherapy People with acuteleukemia need to be treated right away. The goal of treatment is to destroy signs of leukemia in the body and make symptoms go away. This is called a remission. After people go into remission, more therapy may be given to prevent a relapse.
  • 48.
    The3 phasesof treatment protocolsare; Induction phase; the usual criteria for complete remission are 5% of the bone marrow cells and normal peripheral blood counts. Once remission completes the consolidation phase begins.
  • 49.
    Consolidation phase; modified courseof intensive chemotherapy are given to eradicate any remaining disease. Usually a higher dose of 1or more chemotherapeutic agents are administered.
  • 50.
    Maintainance phase; smalldose of different combination of chemotheraptic agents are given every 3 to 4 weeks. This phase may continue for a year or longer and is structured to allow the client to live as normal life as possible
  • 51.
    Targetedtherapy This affects onlytumor cells and spare normal cells. hence decreasing the associated toxicities. Gemtuzumab ozofamicin (mylotarg) is an anti D33nmonoclonal antibody linked to calicheamicin, which is potent cytotoxic agent.
  • 52.
    STEM CELLTRANSPLANT Goal; Totally eliminateleukemic cells from the body using combinations of chemotherapy with or without total bodyirradiation Eradicates patient’s hematopoietic stem cells Replaced with those of an HLA-matched (Human LeukocyteAntigen)
  • 53.
    Sibling (is abrother or a sister; that is, any person who shares at least one of the same parents ) Volunteer Identical twin Patient’s own stemcells removed before
  • 54.
    TYPESOFSTEMCELLTRANSPLANTATION 1.Allogeneic StemCell Transplant stemcells are taken from a matching donor. To determine if a donor’s stem cells are the right match, the patient undergoes a human leukocyte antigens (HLA) test. Through this test, we compare the patient’s blood and tissue type against blood samples from thedonor.
  • 55.
    Donors may include: HLA-matchedrelative (most often a sibling) HLA-matched unrelated donor HLA miss-matched family member Unrelated umbilical cord blood
  • 56.
    2. Autologous StemCell Transplant In this type of transplant, stem cells are collected from the patient themselves. The stem cells are then harvested, frozen and stored, and then given back to the patient. This type of transplant is rare for leukemia patients and is typically used in select cases of AML.
  • 57.
    Nutrition and PhysicalActivity It's important for you to take care of eating well and staying as active. right amount of calories to maintain a good weight. enough protein. Eating well may help to feel better and have more energy.
  • 58.
    Follow-up Care regular checkupsafter treatment for leukemia.
  • 59.
  • 60.
    Nursing diagnosis 1.Impaired oralmucous membrane relatedto low platelet counts or effect of pathologic conditions and treatment. 2. Ineffective therapeutic management related to lack of knowledge of disease process, activity and medication. 3. imbalanced nutrition less than body requirement reated to anorexia , pain and fatigue. 4. risk for injury related to low platelet counts and treatment
  • 61.
    Overall goals Understand andcooperate with the treatment plan Experience minimal side effects and complications of disease and treatment Feel hopeful and supported during the periods of treatment, relapse, and remission Many physical and psychologicalneeds Evokes great fear
  • 62.
  • 63.